The sharp 20 per cent correction in the stock price, more or less captures the value of the incremental liability, over and ...
The #ASX200 logged a series of record highs this week, recovering from a sharp pullback in early August. Many investors are ...
Banks may see a relief rally due to short-term improvement in liquidity and improved deposit growth. Emkay Global said it ...
Stocks @ Night is a daily newsletter delivered after hours, giving you a first look at tomorrow and last look at today. Sign up for free to receive it directly in your inbox. Here's what CNBC TV's ...
The company closed down nearly 6%, at $14.70, as the six-month lockup period preventing insiders from selling the stock ...
The latest batch of quarterly forecasts from the Federal Reserve showed policy makers have had a change of heart since June ...
Wall Street romped to records as a delayed jubilation swept markets worldwide following the Federal Reserve’s big cut to ...
The S&P 500 soared 1.7% on Thursday, Sept. 19, notching a record closing high a day after the Fed opted for an aggressive ...
Key Takeaways Shares of Truth Social’s parent company fell Thursday, extending the stock's latest round of declines.The stock ...
Indexes rallied Thursday, with tech stocks leading the Nasdaq to rise 2.5% as investors continued to digest Wednesday's jumbo ...
The blue chip index closed above the psychologically significant 42,000 level for the first time ever Thursday.
Shares of biopharma outfit Edgewise Therapeutics (NASDAQ: EWTX) soared more than 50% today, reaching a three-year high following an update on the clinical testing of its cardiac drug EDG-7500. The ...